Literature DB >> 28647069

Oncologic Quality Indicators in Thoracic Surgery.

Jessica Hudson1, Tara Semenkovich1, Varun Puri2.   

Abstract

This article outlines a structure for assessing thoracic surgical quality and provides an overview of evidence-based quality metrics for surgical care in both lung cancer and esophageal cancer, with a focus on process and outcome measures in the preoperative, intraoperative, and postoperative setting.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Esophageal cancer; Lung cancer; Lymphadenectomy; Multidisciplinary treatment; Quality; R0 resection; Staging

Mesh：

Year:  2017        PMID： 28647069      PMCID： PMC5914534          DOI： 10.1016/j.thorsurg.2017.04.001

Source DB:  PubMed          Journal:  Thorac Surg Clin            Impact factor:   1.750


  60 in total

1.  Patterns of surgical care of lung cancer patients.

Authors:  Alex G Little; Valerie W Rusch; James A Bonner; Laurie E Gaspar; Mark R Green; W Richard Webb; Andrew K Stewart
Journal:  Ann Thorac Surg       Date:  2005-12       Impact factor: 4.330

2.  Executive Summary: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Frank C Detterbeck; Sandra Zelman Lewis; Rebecca Diekemper; Doreen Addrizzo-Harris; W Michael Alberts
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

3.  Significance of Microscopically Incomplete Resection Margin After Esophagectomy for Esophageal Cancer.

Authors:  Sheraz R Markar; Caroline Gronnier; Alain Duhamel; Arnaud Pasquer; Jérémie Théreaux; Mael Chalret du Rieu; Jérémie H Lefevre; Kathleen Turner; Guillaume Luc; Christophe Mariette
Journal:  Ann Surg       Date:  2016-04       Impact factor: 12.969

4.  A comparison of multimodal therapy and surgery for esophageal adenocarcinoma.

Authors:  T N Walsh; N Noonan; D Hollywood; A Kelly; N Keeling; T P Hennessy
Journal:  N Engl J Med       Date:  1996-08-15       Impact factor: 91.245

5.  Long-term Survival Based on the Surgical Approach to Lobectomy For Clinical Stage I Nonsmall Cell Lung Cancer: Comparison of Robotic, Video-assisted Thoracic Surgery, and Thoracotomy Lobectomy.

Authors:  Hao-Xian Yang; Kaitlin M Woo; Camelia S Sima; Manjit S Bains; Prasad S Adusumilli; James Huang; David J Finley; Nabil P Rizk; Valerie W Rusch; David R Jones; Bernard J Park
Journal:  Ann Surg       Date:  2017-02       Impact factor: 12.969

6.  Randomized controlled trial of the role of positron emission tomography in the management of stage I and II non-small-cell lung cancer.

Authors:  Rosalie C Viney; Michael J Boyer; Madeleine T King; Patricia M Kenny; Christine A Pollicino; Jocelyn M McLean; Brian C McCaughan; Michael J Fulham
Journal:  J Clin Oncol       Date:  2004-06-15       Impact factor: 44.544

7.  Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  John A Howington; Matthew G Blum; Andrew C Chang; Alex A Balekian; Sudish C Murthy
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

8.  Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Gerard A Silvestri; Anne V Gonzalez; Michael A Jantz; Mitchell L Margolis; Michael K Gould; Lynn T Tanoue; Loren J Harris; Frank C Detterbeck
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

9.  Staging investigations for oesophageal cancer: a meta-analysis.

Authors:  E P M van Vliet; M H Heijenbrok-Kal; M G M Hunink; E J Kuipers; P D Siersema
Journal:  Br J Cancer       Date:  2008-01-22       Impact factor: 7.640

Review 10.  Minimally Invasive Methods for Staging in Lung Cancer: Systematic Review and Meta-Analysis.

Authors:  Gonzalo Labarca; Carlos Aravena; Francisco Ortega; Alex Arenas; Adnan Majid; Erik Folch; Hiren J Mehta; Michael A Jantz; Sebastian Fernandez-Bussy
Journal:  Pulm Med       Date:  2016-10-13
View more
  5 in total

1.  Multidisciplinary consensus statement on the clinical management of patients with stage III non-small cell lung cancer.

Authors:  M Majem; J Hernández-Hernández; F Hernando-Trancho; N Rodríguez de Dios; A Sotoca; J C Trujillo-Reyes; I Vollmer; R Delgado-Bolton; M Provencio
Journal:  Clin Transl Oncol       Date:  2019-06-06       Impact factor: 3.405

2.  Effectiveness evaluation of adjuvant concurrent chemoradiotherapy for patients with positron emission tomography-staged esophageal squamous cell carcinoma after complete resection: A population-based cohort study.

Authors:  Hsin-Yuan Fang; Yu-Sen Lin; Chien-Kuang Chen; Jian-Xun Chen; Ting-Yu Lu; Tzu-Min Huang; Te-Chun Hsieh; Yu-Cheng Kuo; Chen-Yuan Lin; Ming-Yu Lien; Chi-Ching Chen; Chia-Chin Li; Chun-Ru Chien
Journal:  Thorac Cancer       Date:  2022-06-03       Impact factor: 3.223

3.  Social determinants and facility type impact adherence to best practices in operable IIIAN2 lung cancer.

Authors:  Zaid Muslim; Stephanie Stroever; Mirza Zain Baig; Joanna F Weber; Cliff P Connery; Faiz Y Bhora
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-08-19

4.  Predicting Prognosis and Adverse Events by Hematologic Markers in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy.

Authors:  Guoxin Cai; Jinming Yu; Xue Meng
Journal:  Cancer Manag Res       Date:  2020-09-15       Impact factor: 3.989

5.  Analysis of Delayed Surgical Treatment and Oncologic Outcomes in Clinical Stage I Non-Small Cell Lung Cancer.

Authors:  Brendan T Heiden; Daniel B Eaton; Kathryn E Engelhardt; Su-Hsin Chang; Yan Yan; Mayank R Patel; Daniel Kreisel; Ruben G Nava; Bryan F Meyers; Benjamin D Kozower; Varun Puri
Journal:  JAMA Netw Open       Date:  2021-05-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.